Frank X. Curci is a Partner in Buchalter's Portland and Scottsdale offices, a member of the Firm's Corporate and Intellectual Property Practice Groups, and serves as Co-Chair of the MedTech & Life Sciences Industry Group and the Privacy & Data Security Law Industry Group. His practice focuses on the representation of high-tech companies (ranging from emerging growth companies to global companies), bioscience industry companies, universities/research institutions, global technology consortia, technology accelerators, and other technology-based companies.

He counsels these clients concerning a range of matters, including patent/technology licensing, technology collaborations & consortia (including technology standards), research matters, technology transfer, the overall protection, commercialization and use of the client's intellectual property rights, data privacy and security matters, and data sharing/data ownership issues.

Mr. Curci has a recognized bioscience practice representing universities/research institutions and bioscience companies regarding licensing, technology transfer, collaborations, research, and other technology commercialization matters. Click here for more information about the firm's University, Research Institution and Technology Transfer Practice Group.

He has earned a national reputation in the high tech industry for his work regarding the formation, structuring, and ongoing operations of global technology consortia and other technology collaborations (including standards organizations). Click here for more information about the firm's Global Standards and Technology Consortia Group.

Mr. Curci is active with high technology and bioscience-related associations. For several years he has been an Adjunct Professor of Law teaching intellectual property law courses at Oregon, Arizona and California law schools.

He has received The Best Lawyers in America® (2009-2027) recognition in the Technology Law and Biotechnology Law fields. In 2017 and 2018 Frank was named to the Oregon Super Lawyers list. He also has an AV Rating® from Martindale-Hubbell®.

Show MoreShow Less

Bar Admissions
Oregon

New York

Arizona

Washington

Education
Fordham University School of Law, 1984

Manhattan College, B.A., summa cum laude, 1981 - Phi Beta Kappa

Significant Accomplishments

High Technology & General Intellectual Property Matters

• Counsel clients regarding development, protection, commercialization, and other strategic uses of technology/IP rights, including: (i) patent/technology licensing; (ii) technology collaborations; (iii) technology distribution arrangements (including resellers/OEMs); (iv) open source software issues; (v) e-commerce/internet-based businesses; (vi) trademark use and protection; and (vii) additional technology acquisition and transfer matters.
• Represent leading high tech companies, and serve as main outside counsel to global technology consortia entities, regarding the formation, structuring, and ongoing operations of global technology consortia, including technology standards organizations.
• Counsel technology accelerator/incubator entities regarding technology commercialization matters and investments in early stage companies.

Bioscience Industry Matters

• Represent several bioscience research institutions concerning patent/technology licensing, collaborations, other technology commercialization matters, IP policy matters, clinical trial agreements, and the formation of spin out companies.
• Represent emerging growth medical device and other bioscience companies concerning patent/technology licensing, collaborations, and other intellectual property matters.

International Business Matters

• Earlier in his career was a "Visiting Attorney" at the Tokyo, Japan law firm of Matsuo & Kosugi counseling mostly Japanese corporations in international licensing and other business transactions. Frank's practice has had an international component since that time.

Additional Commercial and Business Matters

• Represents clients in numerous commercial and corporate transactions, including acquisitions, creation of spin outs, creation of technology accelerators, equity and debt investments in startups, and other business transactions described above.

• Buchalter COVID-19 Client Alert: San Francisco Moves to Lowest COVID Tier in California, Begins Process of Reopening Non-Essential Offices; Other Bay Area Counties Slower to Follow

  By Frank Curci |November 2020

• Buchalter COVID-19 Client Alert: San Francisco Moves to Lowest COVID Tier in California, Begins Process of Reopening Non-Essential Offices; Other Bay Area Counties Slower to Follow

  By Frank Curci |November 2020

• Buchalter COVID-19 Client Alert: San Francisco Moves to Lowest COVID Tier in California, Begins Process of Reopening Non-Essential Offices; Other Bay Area Counties Slower to Follow

  By Frank Curci |November 2020

Additional ArticlesWindfalls and Pitfalls of Pivoting Your Business Model in the New Business Environment

What Does the EU-US Data Privacy Framework Mean for Your Business?

The Oregon Consumer Privacy Act ("OCPA"): What Businesses Need to Know

Before You Sign: Red Flag Issues For Healthcare Companies and AI Vendor Contracts

Buchalter Attorneys Speaking at Arizona State University GETS Conference, May 2026

How Standards Bodies and Research Universities Can Both Benefit Through Collaborations